The Latest
Abbott’s SCS System Cleared for Patients With Painful Diabetic Peripheral Neuropathy
Trial Evaluating Lisocabtagene Maraleucel for Relapsed/Refractory CLL Meets Endpoint
Briumvi Now Available for Multiple Sclerosis Treatment
AHA Presents Up-To-Date Statistics for Cardiovascular Disease
Sleep Medication Used by 8.4% of Adults in 2020
High-Dose Exercise No Better Than Low-Dose Exercise for Knee Osteoarthritis
Trial Investigating Pembrolizumab for Hormone-Sensitive Prostate Cancer Discontinued
FDA Panel Votes on Rezafungin for Treatment of Candidemia, Invasive Candidiasis
AKI, CKD Progression Less Likely With Direct Oral Anticoagulants
Get the latest news in our COVID-19 Resource Center.MPR ARTICLES
